Mutual Advisors LLC Sells 267 Shares of CME Group Inc. $CME

Mutual Advisors LLC reduced its holdings in CME Group Inc. (NASDAQ:CME) by 9.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,479 shares of the financial services provider’s stock after selling 267 shares during the quarter. Mutual Advisors LLC’s holdings in CME Group were worth $693,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Generali Asset Management SPA SGR increased its holdings in shares of CME Group by 91.7% in the second quarter. Generali Asset Management SPA SGR now owns 7,550 shares of the financial services provider’s stock worth $2,081,000 after acquiring an additional 3,612 shares in the last quarter. Ritholtz Wealth Management grew its holdings in shares of CME Group by 22.6% during the second quarter. Ritholtz Wealth Management now owns 5,455 shares of the financial services provider’s stock worth $1,503,000 after buying an additional 1,004 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its holdings in shares of CME Group by 12.5% during the second quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 3,155 shares of the financial services provider’s stock worth $870,000 after buying an additional 350 shares in the last quarter. Bayforest Capital Ltd bought a new position in shares of CME Group during the second quarter worth about $114,000. Finally, Sagespring Wealth Partners LLC grew its holdings in shares of CME Group by 4.1% during the second quarter. Sagespring Wealth Partners LLC now owns 25,415 shares of the financial services provider’s stock worth $7,005,000 after buying an additional 997 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard acquired 262 shares of the business’s stock in a transaction dated Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares in the company, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 13,043 shares of company stock valued at $3,527,956. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CME. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Oppenheimer increased their price objective on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Morgan Stanley increased their price objective on CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, October 1st. Finally, Barclays decreased their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $283.71.

CME Group Stock Up 2.1%

CME stock opened at $267.93 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business has a 50 day moving average price of $267.30 and a two-hundred day moving average price of $271.38. The company has a market cap of $96.56 billion, a price-to-earnings ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the company earned $2.56 earnings per share. The business’s revenue was up 10.4% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.